Therapeutic Asset Ratings

9,928 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Baff Car-T B-Cell Chronic Lymphocytic Leukemia	Paolo Caimi, MD	P1	CC (43)
Baff Car-T Lymphoma	Paolo Caimi, MD	P1	CC (43)
Baff Car-T Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Paolo Caimi, MD	P1	CC (43)
Baffr-Car T Cells B-Cell Acute Lymphoblastic Leukemia	PeproMene Bio, Inc.	P1	CC (43)
Baffr-Car T Cells B-Cell Non-Hodgkin Lymphoma	PeproMene Bio, Inc.	P1	CC (43)
Balstilimab Angiosarcoma	Agenus Inc.	P1	CC (43)
Balstilimab Fibrolamellar Hepatocellular Carcinoma	Agenus Inc.	P1	CC (43)
bar502 Metabolic Dysfunction-Associated Steatohepatitis	BAR Pharmaceuticals s.r.l.	P1	CC (43)
bay2395840 Kidney Failure	Bayer	P1	CC (43)
Bbi-355 Cervical Squamous Cell Carcinoma	Boundless Bio, Inc.	P1	CC (43)
Bbi-355 Skin Squamous Cell Carcinoma	Boundless Bio, Inc.	P1	CC (43)
Bbi-355 Estrogen-Receptor Positive Breast Cancer	Boundless Bio, Inc.	P1	CC (43)
Bbi-355 Head And Neck Squamous Cell Carcinoma	Boundless Bio, Inc.	P1	CC (43)
Bbi-355 Endometrial Carcinoma	Boundless Bio, Inc.	P1	CC (43)
Bbi-355 Leiomyosarcoma	Boundless Bio, Inc.	P1	CC (43)
Bbi-355 Undifferentiated Pleomorphic Sarcoma	Boundless Bio, Inc.	P1	CC (43)
Bbi-825 Cervical Squamous Cell Carcinoma	Boundless Bio, Inc.	P1	CC (43)
Bbi-825 Skin Squamous Cell Carcinoma	Boundless Bio, Inc.	P1	CC (43)
Bbi-825 Estrogen-Receptor Positive Breast Cancer	Boundless Bio, Inc.	P1	CC (43)
Bbi-825 Head And Neck Squamous Cell Carcinoma	Boundless Bio, Inc.	P1	CC (43)
Bbi-825 Endometrial Carcinoma	Boundless Bio, Inc.	P1	CC (43)
Bbi-825 Leiomyosarcoma	Boundless Bio, Inc.	P1	CC (43)
Bbi-825 Undifferentiated Pleomorphic Sarcoma	Boundless Bio, Inc.	P1	CC (43)
Bbo-10203 Neoplasm	TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)	P1	CC (43)
Bbo-10203 HER2 Positive Breast Carcinoma	TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)	P1	CC (43)

Showing 1201 to 1225 of 9,928 assets

PreviousPage 49 of 398Next